← Leaderboards
Kimia Sobhani
Cedars-Sinai Medical Center
$2,501,806
Attributed
$5,003,612
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.8M · FY2019–22$5M$3.8M$2.5M$1.3M$0
'19
'20
'21
'22
Funding mix
By agency
NIH$5,003,612 · 2
By mechanism
U01$5,003,612 · 2
Top collaborators
- Jennifer E Van Eyk5 shared
Most similar at Cedars-Sinai Medical Center
Same institution · by research overlap
- Kenneth E Bernstein$19,603,058
- Homayon Ghiasi$23,295,165
- Mitchell Kronenberg$46,508,740
- Basil Rapoport$8,131,708
- Adrian Friedrich Gombart$3,064,594
Others in their field
Other Emerging Leaders on “Reproducibility”
- Chris Karlovich · Leidos Biomedical Research, Inc.$38,534,220
- Gary Kobinger · University Of Texas Med Br Galveston$34,500,000
- Michelle Lynn Sever · Rho Federal Systems Division, Inc.$26,732,375
- Thomas Denny · Duke University$22,999,550
- Jennifer K Balch · University Of Massachusetts Amherst$14,831,210
- Dana L Tudorascu · University Of Pittsburgh At Pittsburgh$14,519,238
Research focus
ReproducibilityMass Spectrum AnalysisPeptidesProteomic SignatureProtein BiomarkersPerformanceGeneticMonitorPhenotypeProteinsSamplingBiological MarkersPlasmaCandidate MarkerFunctional DisorderGenerationsInsightDyslipidemiasAdipocytesEnzyme ActivityBiological AvailabilityApolipoproteins BDiabetes MellitusEpidemiology
Grant awards (5)
Design and Validation of Easy-to-Adopt Mass Spectrometry Assays of Importance to Obesity$736,762
U01 · FY2022 · DK
Design and Validation of Easy-to-Adopt Mass Spectrometry Assays of Importance to Obesity$736,762
U01 · FY2021 · DK
Design and Validation of Easy-to-Adopt Mass Spectrometry Assays of Importance to Obesity$736,762
U01 · FY2020 · DK
Post-translational modification and protein quantification of plasma and CSF$1,860,708
U01 · FY2019 · NS
Design and Validation of Easy-to-Adopt Mass Spectrometry Assays of Importance to Obesity$932,618
U01 · FY2019 · DK